BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10526397)

  • 1. The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy.
    Kieseier BC; Archelos JJ; Storch M; Gold R; Hartung HP
    Wien Klin Wochenschr; 1999 Sep; 111(17):728-37. PubMed ID: 10526397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis.
    Hafler DA; Slavik JM; Anderson DE; O'Connor KC; De Jager P; Baecher-Allan C
    Immunol Rev; 2005 Apr; 204():208-31. PubMed ID: 15790361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple sclerosis: epidemiology, molecular pathology and therapy].
    Steck AJ; Schaeren-Wiemers N
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1764-8. PubMed ID: 10603650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunopathogenesis of multiple sclerosis.
    Giovannoni G
    Baillieres Clin Neurol; 1997 Oct; 6(3):387-407. PubMed ID: 10101580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future immunotherapies in multiple sclerosis.
    Blevins G; Martin R
    Semin Neurol; 2003 Jun; 23(2):147-58. PubMed ID: 12894380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in pathogenesis and therapy of multiple sclerosis].
    Linker RA; Stadelmann C; Diem R; Bähr M; Brück W; Gold R
    Fortschr Neurol Psychiatr; 2005 Dec; 73(12):715-27. PubMed ID: 16355314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of multiple sclerosis--2. Application of a new immunological basic research is close].
    Svenningsson A; Andersson M; Olsson T
    Lakartidningen; 1998 Dec; 95(49):5631-5. PubMed ID: 9863301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunopathogenesis of multiple sclerosis.
    Prat E; Martin R
    J Rehabil Res Dev; 2002; 39(2):187-99. PubMed ID: 12051463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
    Lim ET; Giovannoni G
    Expert Rev Neurother; 2005 May; 5(3):379-90. PubMed ID: 15938671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific therapies in multiple sclerosis.
    Sospedra M; Martin R
    Int Rev Immunol; 2005; 24(5-6):393-413. PubMed ID: 16318988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the rationale for immunomodulating therapies in multiple sclerosis.
    Lisak RP
    Neurology; 1988 Jul; 38(7 Suppl 2):5-8. PubMed ID: 3290714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF; Martin R
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.
    Buntinx M; Stinissen P; Steels P; Ameloot M; Raus J
    Crit Rev Immunol; 2002; 22(5-6):391-424. PubMed ID: 12803318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic immunomodulation in neurology: from hope to reality. Exemplified by multiple sclerosis].
    Schluep M; Regli F
    Praxis (Bern 1994); 1995 Sep; 84(38):1021-4. PubMed ID: 7481299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of tobacco smoking in etiology of multiple sclerosis--review study].
    Wegrzyn D; Czarnywojtek A; Florek E
    Przegl Lek; 2006; 63(10):1144-5. PubMed ID: 17288241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
    Cassan C; Liblau RS
    J Neurochem; 2007 Feb; 100(4):883-92. PubMed ID: 17181557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent progress in treatment for multiple sclerosis].
    Kira J
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1261-3. PubMed ID: 11464473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.